These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 25269744)
1. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744 [TBL] [Abstract][Full Text] [Related]
2. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518 [TBL] [Abstract][Full Text] [Related]
3. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152 [TBL] [Abstract][Full Text] [Related]
4. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
5. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063 [TBL] [Abstract][Full Text] [Related]
6. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
7. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer. Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964 [TBL] [Abstract][Full Text] [Related]
8. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382 [TBL] [Abstract][Full Text] [Related]
9. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
10. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Sahami-Fard MH; Kheirandish S; Sheikhha MH Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340 [TBL] [Abstract][Full Text] [Related]
12. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. Lian F; Cui Y; Zhou C; Gao K; Wu L PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010 [TBL] [Abstract][Full Text] [Related]
13. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer. Tan HY; Zheng YB; Liu J Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906 [TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. Wang WT; Zhao YN; Han BW; Hong SJ; Chen YQ J Clin Endocrinol Metab; 2013 Jan; 98(1):281-9. PubMed ID: 23118427 [TBL] [Abstract][Full Text] [Related]
15. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer. Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020 [TBL] [Abstract][Full Text] [Related]
18. Circulating miR-34a levels are reduced in colorectal cancer. Nugent M; Miller N; Kerin MJ J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
20. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection. Gao W; Pang D; Yu S J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]